Education
About Us
Working with TipRanks
Follow Us
bioAffinity Technologies, Inc. (BIAF)
NASDAQ:BIAF
RESEARCH TOOLSreports
Total Valuation
bioAffinity Technologies, Inc. has a market cap or net worth of $7.14M. The enterprise value is $8.02M.
Market Cap$7.14M
Enterprise Value$8.02M
Share Statistics
bioAffinity Technologies, Inc. has 27,249,462 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding27,249,462
Owned by Insiders16.15%
Owned by Institutions0.34%
Financial Efficiency
bioAffinity Technologies, Inc.’s return on equity (ROE) is -3.47 and return on invested capital (ROIC) is -218.49%.
Return on Equity (ROE)-3.47
Return on Assets (ROA)-1.39
Return on Invested Capital (ROIC)-218.49%
Return on Capital Employed (ROCE)-2.63
Revenue Per Employee164.25K
Profits Per Employee-158.59K
Employee Count57
Asset Turnover1.44
Inventory Turnover216.73
Valuation Ratios
The current PE Ratio of bioAffinity Technologies, Inc. is -1.22. bioAffinity Technologies, Inc.’s PEG ratio is -0.08.
PE Ratio-1.22
PS Ratio0.00
PB Ratio2.96
Price to Fair Value4.24
Price to FCF-1.07
Price to Operating Cash Flow-0.65
PEG Ratio-0.08
Income Statement
In the last 12 months, bioAffinity Technologies, Inc. had revenue of 9.36M and earned -9.04M in profits. Earnings per share was -0.73.
Revenue9.36M
Gross Profit3.38M
Operating Income-8.95M
Pretax Income-9.03M
Net Income-9.04M
EBITDA-8.33M
Earnings Per Share (EPS)-0.73
Cash Flow
In the last 12 months, operating cash flow was -6.56M and capital expenditures -88.48K, giving a free cash flow of -6.65M billion.
Operating Cash Flow-6.56M
Free Cash Flow-6.65M
Free Cash Flow per Share-0.24
Dividends & Yields
bioAffinity Technologies, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-2.45
52-Week Price Change-89.76%
50-Day Moving Average0.40
200-Day Moving Average1.03
Relative Strength Index (RSI)41.33
Average Volume (3m)4.43M
Important Dates
bioAffinity Technologies, Inc. upcoming earnings date is Aug 19, 2025, TBA Not Confirmed.
Last Earnings DateMay 15, 2025
Next Earnings DateAug 19, 2025
Ex-Dividend Date―
Financial Position
bioAffinity Technologies, Inc. as a current ratio of 0.87, with Debt / Equity ratio of 92.48%
Current Ratio0.87
Quick Ratio0.86
Debt to Market Cap0.06
Net Debt to EBITDA-0.05
Interest Coverage Ratio-96.82
Taxes
In the past 12 months, bioAffinity Technologies, Inc. has paid 11.65K in taxes.
Income Tax11.65K
Effective Tax Rate>-0.01
Enterprise Valuation
bioAffinity Technologies, Inc. EV to EBITDA ratio is -1.37, with an EV/FCF ratio of -1.56.
EV to Sales1.22
EV to EBITDA-1.37
EV to Free Cash Flow-1.56
EV to Operating Cash Flow-1.57
Balance Sheet
bioAffinity Technologies, Inc. has $444.71K in cash and marketable securities with $1.33M in debt, giving a net cash position of $886.46K billion.
Cash & Marketable Securities$444.71K
Total Debt$1.33M
Net Cash$886.46K
Net Cash Per Share$0.03
Tangible Book Value Per Share$0.03
Margins
Gross margin is 34.41%, with operating margin of -95.64%, and net profit margin of -96.56%.
Gross Margin34.41%
Operating Margin-95.64%
Pretax Margin-96.43%
Net Profit Margin-96.56%
EBITDA Margin-88.98%
EBIT Margin-95.45%
Analyst Forecast
The average price target for bioAffinity Technologies, Inc. is $6.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$6.00
Price Target Upside2207.69% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast78.40%
EPS Growth Forecast22.41%